脑部放疗，上午比下午敏感许多！/ }* i3 I8 z# W" K# z& S% h
& v5 f+ e, Z2 `1 j( j. F$ f
) D5 C' m( ?( D# G ~& BCancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9.
: `& J0 |5 x; I v6 f6 K7 hGamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?
0 M) l# m K! O o, U' N }Rahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T.
$ S8 h! u' R5 T# y8 P+ h6 v" LSourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.
8 n, J% @# u" K: i1 ~: T3 \7 [- D- [9 n! \: Z
Abstract8 ~' m7 z5 ~9 x& e0 k7 Z$ _: X/ T
BACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time.
8 o( w% `5 X* p' W: J& P* y
( o2 H' Z; e: ^5 ~; @4 ?% \METHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic.& L0 D1 F$ k# c7 [. G8 I ?
, R2 d& [. m3 Z: y0 g* v
RESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026).& X. j( v; |4 g, |3 s
- ^. U1 C+ {% t* i( y
CONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series.: v ~; K# @( L6 J4 S; Z& z
9 W0 u% R! q2 \
|
$ L9 y& `, Y: p7 }4 T$ _; \4 _; V
显身卡
